Nevro Cash on Hand 2013-2024 | NVRO

Nevro cash on hand from 2013 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Nevro Annual Cash on Hand
(Millions of US $)
2023 $323
2022 $374
2021 $362
2020 $588
2019 $238
2018 $265
2017 $269
2016 $276
2015 $194
2014 $177
2013 $57
2012 $31
Nevro Quarterly Cash on Hand
(Millions of US $)
2024-09-30 $277
2024-06-30 $274
2024-03-31 $281
2023-12-31 $323
2023-09-30 $320
2023-06-30 $330
2023-03-31 $342
2022-12-31 $374
2022-09-30 $387
2022-06-30 $311
2022-03-31 $324
2021-12-31 $362
2021-09-30 $377
2021-06-30 $398
2021-03-31 $576
2020-12-31 $588
2020-09-30 $573
2020-06-30 $562
2020-03-31 $248
2019-12-31 $238
2019-09-30 $233
2019-06-30 $234
2019-03-31 $240
2018-12-31 $265
2018-09-30 $258
2018-06-30 $264
2018-03-31 $260
2017-12-31 $269
2017-09-30 $271
2017-06-30 $263
2017-03-31 $264
2016-12-31 $276
2016-09-30 $288
2016-06-30 $290
2016-03-31 $163
2015-12-31 $194
2015-09-30 $223
2015-06-30 $254
2015-03-31 $159
2014-12-31 $177
2014-09-30 $34
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2012-12-31 $31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.214B $0.425B
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.062B 26.20
Intuitive Surgical (ISRG) United States $209.612B 96.16
Alcon (ALC) Switzerland $45.206B 30.25
Edwards Lifesciences (EW) United States $41.870B 26.59
IQVIA Holdings (IQV) United States $38.108B 20.48
IDEXX Laboratories (IDXX) United States $37.713B 43.16
DexCom (DXCM) United States $34.497B 51.95
Mettler-Toledo (MTD) United States $28.642B 32.97
Waters (WAT) United States $24.401B 36.08
STERIS (STE) Ireland $22.253B 25.33
SONOVA HOLDING (SONVY) Switzerland $20.160B 0.00
Hologic (HOLX) United States $14.774B 15.85
Fresenius Medical Care AG KGaA (FMS) Germany $14.260B 14.64
Globus Medical (GMED) United States $11.976B 30.33
Sysmex ADR (SSMXY) Japan $11.771B 36.91
Penumbra (PEN) United States $10.036B 98.31
Masimo (MASI) United States $9.638B 46.64
Glaukos (GKOS) United States $8.562B 0.00
Teleflex (TFX) United States $8.064B 12.86
Integer Holdings (ITGR) United States $4.726B 26.79
Inari Medical (NARI) United States $4.676B 0.00
PROCEPT BioRobotics (PRCT) United States $3.694B 0.00
Veracyte (VCYT) United States $3.371B 101.16
Nihon Kohden (NHNKY) Japan $2.700B 14.76
LivaNova (LIVN) United Kingdom $2.605B 15.04
TransMedics (TMDX) United States $2.467B 78.19
Tandem Diabetes Care (TNDM) United States $2.413B 0.00
Elekta AB (EKTAY) Sweden $2.332B 20.97
Integra LifeSciences Holdings (IART) United States $2.008B 10.49
Alphatec Holdings (ATEC) United States $1.620B 0.00
RxSight (RXST) United States $1.353B 0.00
Pulse Biosciences (PLSE) United States $1.340B 0.00
Artivion (AORT) United States $1.311B 86.86
OPKO Health (OPK) United States $1.106B 0.00
Paragon 28 (FNA) United States $1.088B 0.00
AxoGen (AXGN) United States $0.807B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.781B 13.27
IRadimed (IRMD) United States $0.778B 42.03
Mesa Laboratories (MLAB) United States $0.770B 16.83
SiBone (SIBN) United States $0.725B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.706B 0.00
Treace Medical Concepts (TMCI) United States $0.640B 0.00
OrthoPediatrics (KIDS) United States $0.574B 0.00
Delcath Systems (DCTH) United States $0.526B 0.00
ClearPoint Neuro (CLPT) United States $0.521B 0.00
Semler Scientific (SMLR) United States $0.463B 24.35
AngioDynamics (ANGO) United States $0.449B 0.00
Pacific Biosciences Of California (PACB) United States $0.438B 0.00
Tactile Systems Technology (TCMD) United States $0.412B 22.30
NeuroPace (NPCE) United States $0.408B 0.00
CVRx (CVRX) United States $0.357B 0.00
Accuray (ARAY) United States $0.277B 0.00
Inogen (INGN) United States $0.258B 0.00
Alpha Tau Medical (DRTS) Israel $0.226B 0.00
Anteris Technologies Global (AVR) Australia $0.222B 0.00
KORU Medical Systems (KRMD) United States $0.222B 0.00
Sight Sciences (SGHT) United States $0.138B 0.00
Rapid Micro Biosystems (RPID) United States $0.133B 0.00
LENSAR (LNSR) United States $0.126B 0.00
Hyperfine (HYPR) United States $0.125B 0.00
Spectral Diagnostics (EDTXF) Canada $0.118B 0.00
Neuronetics (STIM) United States $0.108B 0.00
Atossa Genetics (ATOS) United States $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.100B 15.20
Monogram Orthopaedics (MGRM) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
908 Devices (MASS) United States $0.089B 0.00
Vicarious Surgical (RBOT) United States $0.081B 0.00
InspireMD (NSPR) Israel $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.061B 31.57
Lucid Diagnostics (LUCD) United States $0.057B 0.00
EnVVeno Medical (NVNO) United States $0.055B 0.00
Positron (POSC) United States $0.053B 0.00
Microbot Medical (MBOT) United States $0.044B 0.00
Baird Medical Investment Holdings (BDMD) $0.039B 0.00
Spectral AI (MDAI) United States $0.037B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.032B 0.00
WORK Medical Technology Group (WOK) China $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
NexGel (NXGL) United States $0.023B 0.00
DarioHealth (DRIO) United States $0.021B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Aspira Women's Health (AWH) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Tenon Medical (TNON) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00